The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Khomitskaya Yu.V.

JSC Servier

Suvorov N.I.

JSC Sanofi Russia

Patient reported outcomes: practical and methodological considerations

Authors:

Khomitskaya Yu.V., Suvorov N.I.

More about the authors

Read: 261 times


To cite this article:

Khomitskaya YuV, Suvorov NI. Patient reported outcomes: practical and methodological considerations. Medical Technologies. Assessment and Choice. 2025;47(3):22‑33. (In Russ.)
https://doi.org/10.17116/medtech20254703122

References:

  1. Sharma NS. Patient centric approach for clinical trials: Current trend and new opportunities. Perspectives in Clinical Research. 2015;6(3):134-138.  https://doi.org/10.4103/2229-3485.159936
  2. Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Related Outcome Measures. 2018;9:353-367.  https://doi.org/10.2147/PROM.S156279
  3. Mukhina SM, Orlova EV. Patient-reported outcomes: an overview of applications. Real`naya klinicheskaya praktika: danny`e i dokazatel`stva. 2022;2(2):1-7. (In Russ.). https://doi.org/10.37489/2782-3784-myrwd-12
  4. Khatkov IE, Minaeva OA, Domrachev SA, Priymak MA, Solovyev NO, Tyutyunnik PS. PROM a contemporary approach to assessing the quality of life of patients with cancer. Terapevticheskii arkhiv. 2022;94(1):122-128. (In Russ.). https://doi.org/10.26442/00403660.2022.01.201343
  5. Alekseeva AP. Assessment of the quality of life of patients with cancer: Current state of the problem. Rossijskij onkologicheskij zhurnal. 2021;26(3):93-99. (In Russ.). https://doi.org/10.17816/onco106648
  6. Issledovaniya real`noj klinicheskoj praktiki. Obnovlyonny`e rekomendacii 2023 goda. Pod obshhej redakciej Kolbina ASM.: Izdatel`stvo OKI; 2023. (In Russ.).
  7. Johnston BC, Patrick DL, Devji T, Maxwell LJ, Bingham III CO, Beaton D, et al. Chapter 18: Patient-reported outcomes. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.4 (updated August 2023). Cochrane, 2023. Accessed November 11,2024. https://training.cochrane.org/handbook/current/chapter-18
  8. Churruca K, Pomare C, Ellis LA, Long JC, Henderson SB, Murphy LED, et al. Patient-reported outcome measures (PROMs): A review of generic and condition-specific measures and a discussion of trends and issues. Health Expectations. 2021;24(4):1015-1024. https://doi.org/10.1111/hex.13254
  9. Desomer A, van den Heede K, Triemstra M, Paget J, De Boer D, Kohn L, et al. Use of patient-reported outcome and experience measures in patient care and policy. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2018. KCE Reports 303. D/2018/10.273/40. Accessed November 11,2024. https://www.nivel.nl/sites/default/files/bestanden/KCE_use_of_PROM_PREM.pdf
  10. Cella D, Hahn EA, Jensen SE, Butt Z, Nowinski CJ, Rothrock N, Lohr KN. Patient-Reported Outcomes in Performance Measurement. Research Triangle Park (NC): RTI Press; 2015 Sep.  https://doi.org/10.3768/rtipress.2015.bk.0014.1509
  11. Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value in Health. 2007;10 Suppl 2:S125-S137. https://doi.org/10.1111/j.1524-4733.2007.00275.x
  12. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European Journal of Cancer. 2009;45(3):347-353.  https://doi.org/10.1016/j.ejca.2008.09.032
  13. Teixeira MM, Borges FC, Ferreira PS, Rocha J, Sepodes B, Torre C. A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020. Frontiers in Medicine. 2022;9:968272. https://doi.org/10.3389/fmed.2022.968272
  14. Cella D, Chen CI, Quek RGW, Uribarren A, Reaney M, Mastey V, et al. Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions. Frontiers in Pharmacology. 2022;13:1031992. https://doi.org/10.3389/fphar.2022.1031992
  15. Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics Guidance for Industry. 2018. Accessed November 10,2024. https://www.fda.gov/media/71195/download
  16. Di Maio M, Basch E, Denis F, Fallowfield LJ, Ganz PA, Howell D, et al. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Annals of Oncology. 2022;33(9):878-892.  https://doi.org/10.1016/j.annonc.2022.04.007
  17. Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, et al. Reporting of Patient-Reported Outcomes in Randomized Trials. JAMA. 2013;309(8):814.  https://doi.org/10.1001/jama.2013.879
  18. Gnanasakthy A, Levy C, Norcross L, Doward L, Winnette R. A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021). Value in Health. 2023;26(6):893-901.  https://doi.org/10.1016/j.jval.2023.01.017
  19. Haag S, Junge L, Lotz F, McGauran N, Paulides M, Potthast R, Kaiser T.Results on patient-reported outcomes are underreported in summaries of product characteristics for new drugs. Journal of Patient-Reported Outcomes. 2021;5(1):127.  https://doi.org/10.1186/s41687-021-00402-1
  20. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims: Guidance for Industry. US Food and Drug Administration. Accessed November 10,2024. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims.
  21. Calvert M, King M, Mercieca-Bebber R, Aiyegbusi O, Kyte D, Slade A, et al. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials. BMJ Open. 2021;11(6):e045105. https://doi.org/10.1136/bmjopen-2020-045105
  22. Elenevskaya M, Ovchinnikova I. Russian-speaking associations of Israelis as a reflection of changes in language and culture. Voprosy` psixolingvistiki. 2015;(24):226-241. (In Russ.).
  23. Mohamad Adam B, Hon YK, Lee KY. A step-by-step guide to questionnaire validation research. Kuala Lumpur, Malaysia: Institute for Clinical Research, NIH MY; 2022. https://doi.org/10.5281/zenodo.6801209
  24. Hoffmann C, McFarland BH, Kinzie JD, Bresler L, Rakhlin D, Wolf S, et al. Psychometric properties of a Russian version of the SF-12 Health Survey in a refugee population. Comprehensive Psychiatry. 2005;46(5):390-397.  https://doi.org/10.1016/j.comppsych.2004.12.002
  25. Akulaev AA, Ivanov AA, Ionova TI, Nikitina TP, Tishhenkov KA, Povalij AA. Validation and evaluation of the Russian version of the SEFAS questionnaire for assessing foot and ankle in surgically treated patients with forefoot disorders. Genij ortopedii. 2024;30(2):221-233. (In Russ.). https://doi.org/10.18019/1028-4427-2024-30-2-221-233
  26. What Is Concurrent Validity? Definition & Examples. Accessed November 10,2024. https://www.scribbr.com/methodology/concurrent-validity/

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.